Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference Held in Chuxiong, Yunnan Province

CHUXIONG, China, Oct. 24, 2024 /PRNewswire/ -- The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference was held in Chuxiong,Yunnan Province onOctober 21. The event was co-sponsored by the China Association of Chinese...

2024-10-24 15:48 4753

Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterations

Pierre Fabre Laboratories Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-002/VERT-002, an Innovative Targeted Therapy Intended to Treat Non-Small Cell Lung Cancer with MET Alterations PFL-002/VERT-002 is a monoclonal antibody with a novel and differentiated mechanism of action,...

2024-10-24 15:15 1802

Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterations

Founder of Hua Medicine Dr. Li CHEN was awarded the "C.C. Tan Life Science Industrialization Award"

SHANGHAI, Oct. 24, 2024 /PRNewswire/ -- The 17th "C.C. Tan Life Science Award" ceremony was held inShenyang, China, on October 9th. Dr. Li CHEN, Founder and Chief Executive Officer of Hua Medicine, was awarded the "C.C. Tan Life Science Industrialization Award". C.C. Tan Life Science Award has th...

2024-10-24 13:16 4638

Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers

Designed to make next-generation sequencing accessible to more labs With room-temperature kit storage and shipping, Illumina's newest sequencers remove barriers to enable more insights and discoveries SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA ...

2024-10-24 10:00 2116

Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

HMI-115 has demonstrated statistically significant improvement in endometriosis pain The mean dysmenorrhea pain score was reduced by 42% The mean non-menstrual pelvic pain score was reduced by 50% Most of the patients reported normal menstrual periods No typical peri-menopausal symptoms were re...

2024-10-24 08:08 3829

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

Lycored Introduces Lycomato⁶ ™ Beadlets, Expanding Applications and Branding for Flagship Wellness Extract

BRANCHBURG, N.J., Oct. 24, 2024 /PRNewswire/ -- Lycored, the global leader in naturally derived carotenoids for food, beverage, and dietary supplement products, has launched Lycomato6 ™ Beadlets 5%—a new delivery format for their premier anti-inflammaging solution. This release comes at the same ...

2024-10-24 08:00 1403

FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

MELBOURNE, Australia, Oct. 24, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces thatthe United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara®[1]), an agent for the imaging of g...

2024-10-24 06:02 1505

Caliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat Reduction

* The first and only lipolytic injectable for large area – CBL-514's last Phase2b study has been completed * Both CBL-514 Phase 2b studies used efficacy assessment tools, AFRS and MRI, in accordance with the U.S. FDA recommendation * CBL-514 Pivotal Phase 3 study is expected to initiate subj...

2024-10-24 01:42 1550

CorDx Selects MasterControl to Streamline Life Science Quality and Manufacturing Processes Globally

IVD leader adopts MasterControl Qx and Mx platforms to ensure regulatory compliance acrossChina, the US and more. SINGAPORE, Oct. 23, 2024 /PRNewswire/ -- MasterControl announced today that CorDx Inc., the global diagnostics company and leader in IVD research and development, has chosen MasterCo...

2024-10-23 23:17 1443

AXA BetterMe Weekend concludes with resounding success, drawing close to 13,000 participants

Promoting physical and mental well-being, living out a BetterMe together, in West Kowloon filled with laughter and vitality HONG KONG, Oct. 23, 2024 /PRNewswire/ -- AXA BetterMe Weekend, the iconic annual community carnival hosted by AXA Hong Kong andMacau (AXA), was successfully held onOctober ...

2024-10-23 18:18 2555

AXA BetterMe Weekend concludes with resounding success, drawing close to 13,000 participants

CCTV+: Explore the Wizard of Oz in Jiangzhong Pharmaceutical Valley

BEIJING, Oct. 23, 2024 /PRNewswire/ -- This is a report from CCTV+: Want to cool down in the hot summer? Better to explore the Wizard of Oz in Jiangzhong Pharmaceutical Valley. In this wonderful green garden, you can meet muntjacs and birds. The ancient legend of Shennong tasted herbs is also u...

2024-10-23 15:38 2905

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

* This approval paves the way for exports to the world's fourth most populous country. * SK bioscience aims to continue to grow as a global vaccine brand beyond Korea. SEONGNAM, South Korea, Oct. 23, 2024 /PRNewswire/ -- SK bioscience , a global innovativ...

2024-10-23 15:11 1384

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

TraceLink's New Singapore Office Fuels Expansion and Operational Excellence in APAC

Strengthening Regional Presence and Increasing Support for APAC Customers SINGAPORE, Oct. 23, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has announced the opening of its new office inSingapore. This expansion ...

2024-10-23 10:00 1395

Australia's Healthcare Innovators in Stroke and Paediatric Care Honoured at 2024 Challenger Summit

Life sciences investor Proto Axiom awards $250,000 in prizes at inaugural Summit SYDNEY, Oct. 23, 2024 /PRNewswire/ -- The 2024 Challenger Summit concluded with two visionary researchers recognised for their groundbreaking contributions to treatment of stroke and paediatric skin care. The Summit...

2024-10-23 09:29 1380

AIMed 2024: A Pioneer in Healthcare Innovation to Join Key AI in Medicine Event

SAN ANTONIO, Oct. 23, 2024 /PRNewswire/ -- Frost & Sullivan proudly announce that Reenita Das, Partner and Senior Vice President of Healthcare & Life Sciences, will attend the highly anticipated AIMed 2024 Global Summit. The event, held fromNovember 17 - 19, 2024, 2024, will bring together health...

2024-10-23 00:03 1330

Harnessing Generative AI in Healthcare and Improving Cardiometabolic Health with Precision Medicine: Key Opportunities and Insights

HOUSTON, Oct. 22, 2024 /PRNewswire/ -- In today's rapidly evolving healthcare landscape, two powerful forces are reshaping how we diagnose, treat, and manage health conditions: Generative artificial intelligence (GenAI) and precision medicine for cardiometabolic health. GenAI promises to revoluti...

2024-10-22 22:51 1332

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals

MELBOURNE, Australia, Oct. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the spin-off of Rhine Pharma[1], which has the mission of expanding global access to innovative radiopharmaceuticals for cancer imaging and treatment using two gen...

2024-10-22 18:57 1688

World Psoriasis Day 2024: Psoriatic Disease and Family--Standing Together in Support and Understanding

STOCKHOLM, Oct. 22, 2024 /PRNewswire/ -- Each year on October 29th, the global community unites on World Psoriasis Day to raise awareness and advocate for progress in the fight against psoriatic disease. This year, the focus is on the profound impact of psoriatic disease on families, highlighted ...

2024-10-22 16:00 2196

World Psoriasis Day 2024: Psoriatic Disease and Family--Standing Together in Support and Understanding

Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in "Kidney 360" Magazine

SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the "Kidney 360" magazine has pu...

2024-10-22 07:40 1851

【C.S】Cordyceps Sunshine Biotech Uplists to OTCQB, Aims for a Potential Nasdaq Uplisting

TAIPEI, Oct. 22, 2024 /PRNewswire/ -- Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S】Group, recognized for its expertise in cultivating the rare medicinal fungusTaiwanofungus, native to Taiwan, has reached a significant milestone by uplisting to the OTCQB market.

2024-10-22 06:00 1378

【C.S】Cordyceps Sunshine Biotech Uplists to OTCQB, Aims for a Potential Nasdaq Uplisting

1 ... 13 14 151617 18 19 ... 573